- Home
- VRRM vs AXSM Comparison
VRRM vs AXSM Comparison
Compare VRRM & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRRM
- AXSM
- Stock Information
- Founded
- VRRM 2016
- AXSM 2012
- Country
- VRRM United States
- AXSM United States
- Employees
- VRRM N/A
- AXSM N/A
- Industry
- VRRM Transportation Services
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- VRRM Consumer Discretionary
- AXSM Health Care
- Exchange
- VRRM Nasdaq
- AXSM Nasdaq
- Market Cap
- VRRM 4.0B
- AXSM 4.7B
- IPO Year
- VRRM N/A
- AXSM 2015
- Fundamental
- Price
- VRRM $23.81
- AXSM $86.75
- Analyst Decision
- VRRM Buy
- AXSM Strong Buy
- Analyst Count
- VRRM 3
- AXSM 14
- Target Price
- VRRM $27.33
- AXSM $125.93
- AVG Volume (30 Days)
- VRRM 1.0M
- AXSM 484.5K
- Earning Date
- VRRM 10-31-2024
- AXSM 02-18-2025
- Dividend Yield
- VRRM N/A
- AXSM N/A
- EPS Growth
- VRRM 31.49
- AXSM N/A
- EPS
- VRRM 0.60
- AXSM N/A
- Revenue
- VRRM $868,720,000.00
- AXSM $338,457,000.00
- Revenue This Year
- VRRM $9.63
- AXSM $44.89
- Revenue Next Year
- VRRM $6.18
- AXSM $68.41
- P/E Ratio
- VRRM $39.55
- AXSM N/A
- Revenue Growth
- VRRM 9.64
- AXSM 51.47
- 52 Week Low
- VRRM $20.26
- AXSM $64.11
- 52 Week High
- VRRM $31.03
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- VRRM 52.20
- AXSM 38.08
- Support Level
- VRRM $23.31
- AXSM $84.94
- Resistance Level
- VRRM $24.14
- AXSM $88.59
- Average True Range (ATR)
- VRRM 0.55
- AXSM 3.82
- MACD
- VRRM 0.08
- AXSM -1.01
- Stochastic Oscillator
- VRRM 67.26
- AXSM 14.77
About VRRM Verra Mobility Corporation
Verra Mobility Corp provides smart transportation solutions. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.